RESEARCH on the Dapivirine or Vaginal Ring’s effectiveness and safety in pregnant and lactating women are now at advanced stage as the world prepares to rollout the ring, a tool meant to protect women against the risk of HIV infection, Dr Nyaradzo Mgodi, the Chairperson of Dapivirine ring study in Africa has said. By Patricia Mashiri The Dapivirine Vaginal Ring is a silicone made ring which is inserted into the vagina for a period of 28-35 days releasing antiretroviral drug called Dapivirine reducing the risk of HIV infections. Speaking during…
Read MoreStudies To Determine Dapirivirine Ring’s Safety In Pregnant And Breastfeeding Women Gather Momentum
